BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 28993332)

  • 1. Amikacin Pharmacokinetics To Optimize Dosing in Neonates with Perinatal Asphyxia Treated with Hypothermia.
    Cristea S; Smits A; Kulo A; Knibbe CAJ; van Weissenbruch M; Krekels EHJ; Allegaert K
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28993332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective Evaluation of a Model-Based Dosing Regimen for Amikacin in Preterm and Term Neonates in Clinical Practice.
    Smits A; De Cock RF; Allegaert K; Vanhaesebrouck S; Danhof M; Knibbe CA
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6344-51. PubMed ID: 26248375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gentamicin pharmacokinetics and dosing in neonates with hypoxic ischemic encephalopathy receiving hypothermia.
    Frymoyer A; Meng L; Bonifacio SL; Verotta D; Guglielmo BJ
    Pharmacotherapy; 2013 Jul; 33(7):718-26. PubMed ID: 23553582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy and toxicity of two dosing-regimens of amikacin in neonates with sepsis.
    Abdel-Hady E; El Hamamsy M; Hedaya M; Awad H
    J Clin Pharm Ther; 2011 Feb; 36(1):45-52. PubMed ID: 21198719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The amikacin research program: a stepwise approach to validate dosing regimens in neonates.
    Smits A; Kulo A; van den Anker J; Allegaert K
    Expert Opin Drug Metab Toxicol; 2017 Feb; 13(2):157-166. PubMed ID: 27623706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating renal function and age as predictors of amikacin clearance in neonates: model-based analysis and optimal dosing strategies.
    Illamola SM; Colom H; van Hasselt JG
    Br J Clin Pharmacol; 2016 Sep; 82(3):793-805. PubMed ID: 27198625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetics of vancomycin in term neonates with perinatal asphyxia treated with therapeutic hypothermia.
    van der Veer MAA; de Haan TR; Franken LGW; van Hest RM; Groenendaal F; Dijk PH; de Boode WP; Simons S; Dijkman KP; van Straaten HLM; Rijken M; Cools F; Nuytemans DHGM; van Kaam AH; Bijleveld YA; Mathôt RAA;
    Br J Clin Pharmacol; 2024 Jun; 90(6):1418-1427. PubMed ID: 38450797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population Pharmacokinetic Study of the Suitability of Standard Dosing Regimens of Amikacin in Critically Ill Patients with Open-Abdomen and Negative-Pressure Wound Therapy.
    Carrié C; Delzor F; Roure S; Dubuisson V; Petit L; Molimard M; Breilh D; Biais M
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of Renal Replacement Modalities on Amikacin Population Pharmacokinetics in Critically Ill Patients on Continuous Renal Replacement Therapy.
    Roger C; Wallis SC; Muller L; Saissi G; Lipman J; Lefrant JY; Roberts JA
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4901-9. PubMed ID: 27270279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individualised dosing of amikacin in neonates: a pharmacokinetic/pharmacodynamic analysis.
    Sherwin CM; Svahn S; Van der Linden A; Broadbent RS; Medlicott NJ; Reith DM
    Eur J Clin Pharmacol; 2009 Jul; 65(7):705-13. PubMed ID: 19305985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive Performance of a Gentamicin Pharmacokinetic Model in Term Neonates with Perinatal Asphyxia Undergoing Controlled Therapeutic Hypothermia.
    van der Veer MAA; de Haan TR; Franken LGW; Groenendaal F; Dijk PH; de Boode WP; Simons S; Dijkman KP; van Straaten HLM; Rijken M; Cools F; Nuytemans DHGM; van Kaam AH; Bijleveld YA; Mathôt RAA;
    Ther Drug Monit; 2024 Jun; 46(3):376-383. PubMed ID: 38287875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Population and Developmental Pharmacokinetic Analysis To Evaluate and Optimize Cefotaxime Dosing Regimen in Neonates and Young Infants.
    Leroux S; Roué JM; Gouyon JB; Biran V; Zheng H; Zhao W; Jacqz-Aigrain E
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6626-6634. PubMed ID: 27572399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing gentamicin conventional and extended interval dosing in neonates using Monte Carlo simulation - a retrospective study.
    Bergenwall M; Walker SAN; Elligsen M; Iaboni DC; Findlater C; Seto W; Ng E
    BMC Pediatr; 2019 Sep; 19(1):318. PubMed ID: 31492162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetic modeling and optimal sampling strategy for Bayesian estimation of amikacin exposure in critically ill septic patients.
    Delattre IK; Musuamba FT; Nyberg J; Taccone FS; Laterre PF; Verbeeck RK; Jacobs F; Wallemacq PE
    Ther Drug Monit; 2010 Dec; 32(6):749-56. PubMed ID: 20962708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population Pharmacokinetics and Pharmacodynamic Target Attainment of Ampicillin in Neonates with Hypoxemic-Ischemic Encephalopathy in the Setting of Controlled Hypothermia.
    Cies JJ; Fugarolas KN; Moore WS; Mason RW; Menkiti OR
    Pharmacotherapy; 2017 Apr; 37(4):456-463. PubMed ID: 28226400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amikacin in neonates: dosing recommendations should be based on both pharmacokinetics and dynamics.
    Allegaert K; Sherwin CM
    Singapore Med J; 2010 Jan; 51(1):88-9. PubMed ID: 20200782
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of vancomycin dosing regimens in preterm and term neonates using Monte Carlo simulations.
    Mehrotra N; Tang L; Phelps SJ; Meibohm B
    Pharmacotherapy; 2012 May; 32(5):408-19. PubMed ID: 22488303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic drug monitoring of amikacin in preterm and term neonates with late-onset sepsis. Can saliva samples replace plasma samples?
    Samb A; Sinkeler F; Bijleveld YA; van Kaam A; de Haan TR; Mathôt R
    Br J Clin Pharmacol; 2023 Oct; 89(10):3195-3203. PubMed ID: 37325890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maturation of the glomerular filtration rate in neonates, as reflected by amikacin clearance.
    De Cock RF; Allegaert K; Schreuder MF; Sherwin CM; de Hoog M; van den Anker JN; Danhof M; Knibbe CA
    Clin Pharmacokinet; 2012 Feb; 51(2):105-17. PubMed ID: 22229883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic drug monitoring of amikacin in preterm and term infants.
    Siddiqi A; Khan DA; Khan FA; Razzaq A
    Singapore Med J; 2009 May; 50(5):486-9. PubMed ID: 19495517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.